When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.

Anita D'Souza, MD, discusses an abstract looking at the combination of teclistamab-cqyv, daratumumab, and pomalidomide in 2 ...

No bleeding episodes were seen over three years for 64% of hemophilia A patients given giroctocogene fitelparvovec in a trial ...

Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...

Hematology patients, Gong explains, can have mutations that affect just one or a few base pairs—small insertions or deletions ...

Study of frail older adult patients with myeloma showed reduced disease progression and death with a regimen reducing dexamethasone exposure.

Emma Reeve, the chair of Editas’ board, is also resigning, to be replaced by Jessica Hopfield, Ph.D., the company explained ...

For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for ...

Prelude Therapeutics (Nasdaq: PRLD) presented encouraging interim results from its Phase 1 trial of PRT2527, an ...

Long-term exposure to air pollution poses an increased risk of blood clots in deep veins, which can result in serious ...

STAT reporters discuss why drugmakers have not lobbied against RFK Jr.'s nomination to lead HHS and the struggles around ...